Stock comparison
AbbVie Inc. is 124.1x more valuable than Organon & Co. by market capitalization ($440.14 B vs $3.55 B). Compare market value, revenue, profit, margins, filings, and source pages in one place.
Quick answer
ABBV is larger
AbbVie Inc. is 124.1x more valuable than Organon & Co. by market capitalization ($440.14 B vs $3.55 B).
Market value leader
ABBV
AbbVie Inc. is 124.1x more valuable than Organon & Co. by market capitalization ($440.14 B vs $3.55 B).
Revenue leader
ABBV
OGN: $6.22B vs ABBV: $61.16B.
Profit leader
ABBV
OGN: $187.00M vs ABBV: $4.23B.
Margin leader
ABBV
OGN: 3.0% vs ABBV: 6.9% net margin.
| Metric | OGN | ABBV |
|---|---|---|
| Market cap | $3.55 B | $440.14 B |
| US-listed rank | #1698 | #25 |
| Revenue (latest FY) | $6.22B | $61.16B |
| Net income (latest FY) | $187.00M | $4.23B |
| Net margin | 3.0% | 6.9% |
| P/E (trailing FY) | 19.0x | 104.2x |
| SEC filings | 435 | 1,008 |
Jump from this comparison into the underlying pages for market value, annual fundamentals, and company filing history.
Market cap uses refreshed market data. Revenue, net income, margins, and trailing fiscal-year P/E use annual company facts from filings. If a metric is missing, the source data did not have a clean recent annual value for that company.
AbbVie Inc. is 124.1x more valuable than Organon & Co. by market capitalization ($440.14 B vs $3.55 B).
In their latest fiscal years, Organon & Co. reported $6.22B in revenue while AbbVie Inc. reported $61.16B.
Full pages: Organon & Co. and AbbVie Inc., or browse the full rankings.